<SEC-DOCUMENT>0000950103-22-014796.txt : 20220830
<SEC-HEADER>0000950103-22-014796.hdr.sgml : 20220830
<ACCEPTANCE-DATETIME>20220830164451
ACCESSION NUMBER:		0000950103-22-014796
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20220830
DATE AS OF CHANGE:		20220830

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CREDIT SUISSE AG
		CENTRAL INDEX KEY:			0001053092
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238458-02
		FILM NUMBER:		221215110

	BUSINESS ADDRESS:	
		STREET 1:		PARADEPLATZ 8
		CITY:			ZURICH
		STATE:			V8
		ZIP:			8001
		BUSINESS PHONE:		01141 44 333 1111

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 1
		CITY:			ZURICH
		STATE:			V8
		ZIP:			8070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREDIT SUISSE / /FI
		DATE OF NAME CHANGE:	20050607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CREDIT SUISSE FIRST BOSTON /                            /FI
		DATE OF NAME CHANGE:	19980115
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp179409_424b2-k2139.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 67%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 33%; padding-left: 13px; font-size: 10pt; text-align: right"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 59px; width: 234px"></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: #1F497D; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>FINANCIAL PRODUCTS</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Pricing Supplement No. K2139</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">To the Underlying Supplement dated June 18, 2020,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Product Supplement No. I-B dated June 18, 2020,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Product Supplement No. I-C dated February 4, 2022,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Prospectus Supplement dated June 18, 2020 and</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Prospectus dated June 18, 2020</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="text-align: right; vertical-align: middle">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Registration Statement No. 333-238458-02</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.85pt">August 26, 2022</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%">
    <P STYLE="font: 20pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">$554,000</P>
    <P STYLE="font: 20pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 28pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Buffered Accelerated Return Equity
    Securities due August 31, 2026</FONT></P>
    <P STYLE="font: 28pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Linked to the Performance of the Lowest
    Performing of the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF and the EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></P>
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Investors will not receive any interest or dividend payments and may lose a significant portion of their principal at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>At maturity, if the Final Level of the Lowest Performing Underlying is equal to or greater than its Initial Level, investors will
receive the principal amount of their investment plus a return based on the leveraged upside performance of such Underlying. If the Final
Level of the Lowest Performing Underlying is less than its Initial Level but greater than or equal to its Buffer Level, investors will
receive the principal amount of their investment. However, if the Final Level of the Lowest Performing Underlying is less than its Buffer
Level, investors will lose 1% of their principal for each 1% decline from its Initial Level to its Final Level beyond its Buffer Level.
<B>You could lose up to $900 per $1,000 principal amount</B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Senior unsecured obligations of Credit Suisse maturing August 31, 2026. Any payment on the securities is subject to our ability to
pay our obligations as they become due.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>Minimum purchase of $1,000. Minimum denominations of $1,000 and integral multiples of $1,000 in excess thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>The offering price for the securities was determined on August 26, 2022 (the &ldquo;Trade Date&rdquo;), and the securities are expected
to settle on August 31, 2022 (the &ldquo;Settlement Date&rdquo;). Delivery of the securities in book-entry form only will be made through
The Depository Trust Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>The securities will not be listed on any exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves a number of risks. See &ldquo;Selected
Risk Considerations&rdquo; beginning on page 7 of this pricing supplement and &ldquo;Risk Factors&rdquo; beginning on page&nbsp;PS-3 of
any accompanying product supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of the securities or passed upon the accuracy or the adequacy of this pricing supplement or the
accompanying underlying supplement, any product supplement, the prospectus supplement and the prospectus. Any representation to the contrary
is a criminal offense.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 22%; border: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Price to Public</B><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 40%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Underwriting Discounts and Commissions</B><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Proceeds to Issuer</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Per security</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$1,000</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$38.50</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$961.50</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$554,000</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$21,329</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>$532,671</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>(1)</SUP> Certain fiduciary accounts may pay a purchase price of
at least $961.50 per $1,000 principal amount of securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>(2)</SUP> We or one of our affiliates will pay discounts and commissions
of $38.50 per $1,000 principal amount of securities. CSSU or another broker or dealer will forgo some or all discounts and commissions
with respect to the sales of securities into certain fiduciary accounts. For more detailed information, please see &ldquo;Supplemental
Plan of Distribution (Conflicts of Interest)&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The agent for this offering, Credit Suisse Securities (USA) LLC (&ldquo;CSSU&rdquo;),
is our affiliate. For more information, see &ldquo;Supplemental Plan of Distribution (Conflicts of Interest)&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Credit Suisse currently estimates the value of each $1,000 principal
amount of the securities on the Trade Date is $957.40 (as determined by reference to our pricing models and the rate we are currently
paying to borrow funds through issuance of the securities (our &ldquo;internal funding rate&rdquo;)). See &ldquo;Selected Risk Considerations&rdquo;
in this pricing supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>The securities are not deposit liabilities and are not insured or
guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other
jurisdiction.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Credit Suisse</B>&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">August 26, 2022</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Key Terms</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>



<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Issuer</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Credit Suisse AG (&ldquo;Credit Suisse&rdquo;), acting
through its London branch</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>Underlyings </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The securities are linked to the performance of the lowest
performing of the Underlyings set forth in the table below. For more information on the Underlyings, see &ldquo;The Underlyings&rdquo;
herein. Each Underlying is identified in the table below, together with its Reuters ticker symbol, Initial Level and Buffer Level:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 24%; border-bottom: Black 1pt solid; text-align: center"><B>Underlying</B></TD>
    <TD STYLE="width: 18%; border-bottom: Black 1pt solid; text-align: center"><B>Ticker</B></TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><B>Initial Level</B></TD>
    <TD STYLE="width: 42%; border-bottom: Black 1pt solid; text-align: center"><B>Buffer Level</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">EFA UP &lt;Equity&gt;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$62.71</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$56.439 (90% of Initial Level)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">SX5E &lt;Index&gt;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">3603.68</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">3243.312 (90% of Initial Level)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Redemption Amount</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">At maturity, for each
$1,000 principal amount of securities, you will receive a Redemption Amount in cash that will equal $1,000 multiplied by the sum of one
plus the Security Performance Factor, calculated as set forth below. Any payment on the securities is subject to our ability to pay our
obligations as they become due.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Security Performance Factor</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The Security Performance
Factor is expressed as a percentage and is calculated as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-weight: normal">&middot;</FONT></TD><TD><FONT STYLE="font-weight: normal">If the Final Level of the Lowest Performing Underlying is equal to or greater than its Initial Level,
the Security Performance Factor will equal the product of (i) the Upside Participation Rate multiplied by (ii) the Underlying Return of
the Lowest Performing Underlying.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-weight: normal">&middot;</FONT></TD><TD><FONT STYLE="font-weight: normal">If the Final Level of the Lowest Performing Underlying is less than its Initial Level but greater
than or equal to its Buffer Level, the Security Performance Factor will equal zero.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-weight: normal">&middot;</FONT></TD><TD><FONT STYLE="font-weight: normal">If the Final Level of the Lowest Performing Underlying is less than its Buffer Level, the Security
Performance Factor will equal the sum of (i) the Underlying Return of the Lowest Performing Underlying plus (ii) the Buffer Amount.&#9;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 163.45pt">If the Final Level of the Lowest Performing Underlying
is less than its Buffer Level, the Security Performance Factor will be negative and you will receive less than the principal amount of
your securities at maturity. You could lose up to $900 per $1,000 principal amount.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 163.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Lowest Performing Underlying</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The Underlying with the
lowest Underlying Return.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Underlying Return</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">For each Underlying, an amount calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt; text-align: center"><U>Final Level &ndash; Initial Level</U></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt; text-align: center">Initial Level</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>The Underlying Return for any Underlying will be negative
if its Final Level is less than its Initial Level.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Upside Participation Rate</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">218% </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Buffer Amount</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">10%</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Initial Level</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">For each Underlying,
the closing level of such Underlying on the Trade Date, as set forth in the table above.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Final Level</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">For each Underlying,
the closing level of such Underlying on the Valuation Date.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; margin-left: 127.45pt">
  <TR>
    <TD STYLE="vertical-align: top; width: 33%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold">Trade Date</TD>
    <TD STYLE="vertical-align: top; width: 33%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">August 26, 2022</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 34%; border-top: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold">Settlement Date</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">Expected to be August 31, 2022</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold">Valuation Date</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">August 26, 2026</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Subject to postponement as set forth in any accompanying product supplement under &ldquo;Description of the Securities&mdash;Postponement of calculation dates.&rdquo;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold">Maturity Date</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; font-weight: bold"><FONT STYLE="font-weight: normal">August 31, 2026</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Subject to postponement as set forth in any accompanying product supplement under &ldquo;Description of the Securities&mdash;Postponement of calculation dates.&rdquo; If the Maturity Date is not a business day, the Redemption Amount will be payable on the first following business day, unless that business day falls in the next calendar month, in which case payment will be made on the first preceding business day.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Events of Default</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">With respect to these
securities, the first bullet of the first sentence of &ldquo;Description of Debt Securities&mdash;Events of Default&rdquo; in the accompanying
prospectus is amended to read in its entirety as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol; font-weight: normal">&middot;</FONT></TD><TD><FONT STYLE="font-weight: normal">a default in payment of the principal or any premium on any debt security of that series when due,
and such default continues for 30 days;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">CUSIP</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">22553QFE2</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Additional Terms Specific to the Securities</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">You should read this pricing supplement together with the
underlying supplement dated June 18, 2020, the product supplements dated June 18, 2020 and February 4, 2022, the prospectus supplement
dated June 18, 2020 and the prospectus dated June 18, 2020, relating to our Medium-Term Notes of which these securities are a part. You
may access these documents on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for
the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Underlying Supplement dated June 18, 2020:</TD>
</TR></TABLE>

<P STYLE="text-indent: 0.25in; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000095010320011950/dp130454_424b2-eus.htm">https://www.sec.gov/Archives/edgar/data/1053092/000095010320011950/dp130454_424b2-eus.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Product Supplement No. I-B dated June 18, 2020:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000095010320011955/dp130588_424b2-ps1b.htm">https://www.sec.gov/Archives/edgar/data/1053092/000095010320011955/dp130588_424b2-ps1b.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Product Supplement No. I&ndash;C dated February 4, 2022:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000095010322002048/dp166585_424b2-ic.htm">https://www.sec.gov/Archives/edgar/data/1053092/000095010322002048/dp166585_424b2-ic.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD>Prospectus Supplement and Prospectus dated June 18, 2020:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in"><A HREF="https://www.sec.gov/Archives/edgar/data/1053092/000110465920074474/tm2019510-8_424b2.htm">https://www.sec.gov/Archives/edgar/data/1053092/000110465920074474/tm2019510-8_424b2.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">In the event the terms of the securities described in this
pricing supplement differ from, or are inconsistent with, the terms described in the underlying supplement, any product supplement, the
prospectus supplement or prospectus, the terms described in this pricing supplement will control.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Our Central Index Key, or CIK, on the SEC website is 1053092.
As used in this pricing supplement, &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo; refers to Credit Suisse.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">This pricing supplement, together with the documents listed
above, contains the terms of the securities and supersedes all other prior or contemporaneous oral statements as well as any other written
materials including preliminary or indicative pricing terms, fact sheets, correspondence, trade ideas, structures for implementation,
sample structures, brochures or other educational materials of ours. We may, without the consent of the registered holder of the securities
and the owner of any beneficial interest in the securities, amend the securities to conform to its terms as set forth in this pricing
supplement and the documents listed above, and the trustee is authorized to enter into any such amendment without any such consent. You
should carefully consider, among other things, the matters set forth in &ldquo;Selected Risk Considerations&rdquo; in this pricing supplement
and &ldquo;Risk Factors&rdquo; in any accompanying product supplement, &ldquo;Foreign Currency Risks&rdquo; in the accompanying prospectus,
and any risk factors we describe in the combined Annual Report on Form 20-F of Credit Suisse Group AG and us incorporated by reference
therein, and any additional risk factors we describe in future filings we make with the SEC under the Securities Exchange Act of 1934,
as amended, as the securities involve risks not associated with conventional debt securities. You should consult your investment, legal,
tax, accounting and other advisors before deciding to invest in the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Hypothetical Redemption Amounts at
Maturity</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The table and examples below illustrate hypothetical Redemption
Amounts payable at maturity on a $1,000 investment in the securities for a hypothetical range of performance of the Lowest Performing
Underlying. The table and examples below make the following assumptions. The actual Upside Participation Rate, Buffer Levels and Buffer
Amount are set forth in &ldquo;Key Terms&rdquo; herein. The hypothetical Redemption Amounts set forth below are for illustrative purposes
only. The actual Redemption Amount applicable to a purchaser of the securities will be based on the Final Level of the Lowest Performing
Underlying. It is not possible to predict whether or by how much the Final Level of the Lowest Performing Underlying will be less than
its Buffer Level. You should consider carefully whether the securities are suitable to your investment goals. Any payment on the securities
is subject to our ability to pay our obligations as they become due. The numbers below have been rounded for ease of analysis.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 50%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 42%; border-bottom: Black 1pt solid"><B>Principal Amount&nbsp;</B></TD>
    <TD STYLE="width: 58%; border-bottom: Black 1pt solid">$1,000 per security</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Buffer Level</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">For each Underlying, 90% of its Initial Level </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Buffer Amount</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">10%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Upside Participation Rate</B></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">218% </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; width: 42%">TABLE: Hypothetical Redemption Amounts</TD>
    <TD STYLE="border-top: Black 1pt solid; width: 58%">&nbsp;</TD></TR>
  </TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 42%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Underlying Return of the Lowest Performing Underlying</TD>
    <TD STYLE="width: 24%; border-bottom: black 1pt solid; text-align: center; font-weight: bold"><P STYLE="margin-top: 0; margin-bottom: 0">Security Performance</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Factor</P></TD>
    <TD STYLE="width: 34%; border-bottom: black 1pt solid; text-align: center; font-weight: bold">Redemption Amount per $1,000 Principal Amount of Securities</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">100%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">218%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$3,180</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">90%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">196.20%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,962</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">80%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">174.40%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,744</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">70%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">152.60%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,526</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">60%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">130.80%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,308</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">50%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">109%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$2,090</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">40%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">87.20%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,872</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">30%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">65.40%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,654</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">20%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">43.60%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,436</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">10%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">21.80%</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,218</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;5%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;10%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">0%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9D9D9">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;11%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;1%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$990</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;20%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;10%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$900</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;30%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;20%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$800</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;40%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;30%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$700</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;50%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;40%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$600</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;60%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;50%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$500</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;70%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;60%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$400</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;80%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;70%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$300</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;90%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;80%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$200</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;100%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&minus;90%</FONT></TD>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">$100</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The following examples
illustrate how the Redemption Amount is calculated.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 126pt"></TD><TD STYLE="width: 13.5pt">1.</TD><TD>The Lowest Performing Underlying increases by 20% from its Initial Level to its Final Level.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; border-bottom: Black 1pt solid; text-align: center"><B>Underlying</B></TD>
    <TD STYLE="width: 49%; border-bottom: Black 1pt solid; text-align: center"><B>Final Level</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying A</TD>
    <TD STYLE="text-align: center">120% of Initial Level</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying B</TD>
    <TD STYLE="text-align: center">140% of Initial Level</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Because the Final Level of the Lowest Performing Underlying
is equal to or greater than its Initial Level, the Redemption Amount is determined as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR>
    <TD ROWSPAN="3" STYLE="vertical-align: top; width: 25%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Security Performance Factor</FONT></TD>
    <TD STYLE="width: 75%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= Upside Participation Rate &times; Underlying Return of the Lowest Performing Underlying</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= 218% &times; 20%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= 43.60%</FONT></TD></TR>
  <TR>
    <TD ROWSPAN="3" STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Redemption Amount</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; (1 + Security Performance Factor)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; 1.436</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,436</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt">Because the Final Level of the Lowest Performing Underlying
is equal to or greater than its Initial Level, at maturity you would receive a Redemption Amount based on a leveraged return linked to
the appreciation in the level of the Lowest Performing Underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 126pt"></TD><TD STYLE="width: 4.5pt">2.</TD><TD>The Lowest Performing Underlying decreases by 5% from its Initial Level to its Final Level.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; border-bottom: Black 1pt solid; text-align: center"><B>Underlying</B></TD>
    <TD STYLE="width: 49%; border-bottom: Black 1pt solid; text-align: center"><B>Final Level</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying A</TD>
    <TD STYLE="text-align: center">98% of Initial Level</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying B</TD>
    <TD STYLE="text-align: center">95% of Initial Level</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in"><FONT STYLE="font-weight: normal">Because
the Final Level of the Lowest Performing Underlying is less than its Initial Level but equal to or greater than its Buffer Level, the
Redemption Amount is determined as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR>
    <TD STYLE="vertical-align: top; width: 25%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Security Performance Factor</FONT></TD>
    <TD STYLE="width: 75%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= 0%</FONT></TD></TR>
  <TR>
    <TD ROWSPAN="3" STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Redemption Amount</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; (1 + Security Performance Factor)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; 1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Because the Final Level
of the Lowest Performing Underlying is less than its Initial Level but equal to or greater than its Buffer Level, at maturity you would
receive a Redemption Amount equal to $1,000 per $1,000 principal amount of securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 126pt"></TD><TD STYLE="width: 4.5pt">3.</TD><TD>The Lowest Performing Underlying decreases by 40% from its Initial Level to its Final Level.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; border-bottom: Black 1pt solid; text-align: center"><B>Underlying</B></TD>
    <TD STYLE="width: 49%; border-bottom: Black 1pt solid; text-align: center"><B>Final Level</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying A</TD>
    <TD STYLE="text-align: center">60% of Initial Level</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">Underlying B</TD>
    <TD STYLE="text-align: center">95% of Initial Level</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in"><FONT STYLE="font-weight: normal">Because
the Final Level of the Lowest Performing Underlying is less than its Buffer Level, the Redemption Amount is determined as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse; margin-left: 127.45pt">
  <TR>
    <TD ROWSPAN="3" STYLE="vertical-align: top; width: 25%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Security Performance Factor</FONT></TD>
    <TD STYLE="width: 75%; border-top: #A8A8A7 1pt solid; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= Underlying Return of the Lowest Performing Underlying + Buffer Amount</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= &minus;40% + 10%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= &minus;30%</FONT></TD></TR>
  <TR>
    <TD ROWSPAN="3" STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">Redemption Amount</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; (1 + Security Performance Factor)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $1,000 &times; 0.70</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #A8A8A7 1pt solid"><FONT STYLE="font-size: 10pt">= $700</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in"><FONT STYLE="font-weight: normal">Because
the Final Level of the Lowest Performing Underlying is less than its Buffer Level, you will be exposed to any depreciation in the Lowest
Performing Underlying from its Initial Level to its Final Level beyond its Buffer Level.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 130.5pt; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Selected Risk Considerations</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">An investment in the
securities involves significant risks. This section describes material risks relating to an investment in the securities. These risks
are explained in more detail in the &ldquo;Risk Factors&rdquo; section of any accompanying product supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Securities Generally</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>YOUR INVESTMENT IN THE SECURITIES MAY RESULT IN A LOSS
</B>If the Final Level of the Lowest Performing Underlying is less than its Buffer Level, you will lose 1% of your principal for each
1% decline from its Initial Level to its Final Level beyond its Buffer Level. You could lose up to $900 per $1,000 principal amount of
securities. Any payment on the securities is subject to our ability to pay our obligations as they become due.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE SECURITIES ARE SUBJECT TO THE CREDIT RISK OF CREDIT
SUISSE</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Investors are dependent on our ability to pay all amounts
due on the securities and, therefore, if we were to default on our obligations, you may not receive any amounts owed to you under the
securities. In addition, any decline in our credit ratings, any adverse changes in the market&rsquo;s view of our creditworthiness or
any increase in our credit spreads is likely to adversely affect the value of the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>REGARDLESS OF THE AMOUNT OF ANY PAYMENT YOU RECEIVE
ON THE SECURITIES, YOUR ACTUAL YIELD MAY BE DIFFERENT IN REAL VALUE TERMS</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Inflation may cause the real value of any payment you receive
on the securities to be less at maturity than it is at the time you invest. An investment in the securities also represents a forgone
opportunity to invest in an alternative asset that generates a higher real return. You should carefully consider whether an investment
that may result in a return that is lower than the return on alternative investments is appropriate for you.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE SECURITIES DO NOT PAY INTEREST</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We will not pay interest on the securities. You may receive
less at maturity than you could have earned on ordinary interest-bearing debt securities with similar maturities, including other of our
debt securities, since the Redemption Amount is based on the performance of the Lowest Performing Underlying. Because the Redemption Amount
may be less than the amount originally invested in the securities, the return on the securities (the effective yield to maturity) may
be negative. Even if it is positive, the return payable on each security may not be enough to compensate you for any loss in value due
to inflation and other factors relating to the value of money over time.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE PROBABILITY THAT THE FINAL LEVEL OF THE LOWEST PERFORMING
UNDERLYING WILL BE LESS THAN ITS BUFFER LEVEL WILL DEPEND ON THE VOLATILITY OF SUCH UNDERLYING</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&ldquo;Volatility&rdquo; refers to the frequency and magnitude
of changes in the level of an Underlying. The greater the expected volatility with respect to an Underlying on the Trade Date, the higher
the expectation as of the Trade Date that the Final Level of such Underlying could be less than its Buffer Level, indicating a higher
expected risk of loss on the securities. The terms of the securities are set, in part, based on expectations about the volatility of the
Underlyings as of the Trade Date. The volatility of any Underlying can change significantly over the term of the securities. The level
of any Underlying could fall sharply, which could result in a significant loss of principal. You should be willing to accept the downside
market risk of the Underlyings and the potential to lose a significant amount of your principal at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>THE U.S. FEDERAL TAX CONSEQUENCES OF AN INVESTMENT IN
THE SECURITIES ARE UNCLEAR </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">There is no direct legal authority regarding the proper
U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;).
Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the
treatment of the securities as prepaid financial contracts that are treated as &ldquo;open transactions.&rdquo; If the IRS were successful
in asserting an alternative treatment of the securities, the tax consequences of</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">the ownership and disposition of the securities, including
the timing and character of income recognized by U.S. investors and the withholding tax consequences to non-U.S. investors, might be materially
and adversely affected. Even if the treatment of the securities described herein is respected, there is a substantial risk that a security
will be treated as a &ldquo;constructive ownership transaction,&rdquo; with potentially adverse consequences described below under &ldquo;United
States Federal Tax Considerations.&rdquo; Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect the
U.S. federal tax treatment of the securities, possibly retroactively.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Underlyings</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">YOU WILL BE SUBJECT TO RISKS RELATING TO THE RELATIONSHIP
BETWEEN THE UNDERLYINGS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The securities are linked
to the individual performance of each Underlying. As such, the securities will perform poorly if only one of the Underlyings performs
poorly. For example, if one Underlying appreciates from its Initial Level to its Final Level, but the Final Level of the Lowest Performing
Underlying is less than its Buffer Level, you will be exposed to the depreciation of the Lowest Performing Underlying and you will not
benefit from the performance of any other Underlying. Each additional Underlying to which the securities are linked increases the risk
that the securities will perform poorly. By investing in the securities, you assume the risk that the Final Level of at least one of the
Underlyings will be less than its Buffer Level, regardless of the performance of any other Underlying.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">It is impossible to predict
the relationship between the Underlyings. If the performances of the Underlyings exhibit no relationship to each other, it is more likely
that one of the Underlyings will cause the securities to perform poorly. However, if the performances of the equity securities included
in each Underlying are related such that the performances of the Underlyings are correlated, then there is less likelihood that only one
Underlying will cause the securities to perform poorly. Furthermore, to the extent that each Underlying represents a different market
segment or market sector, the risk of one Underlying performing poorly is greater. As a result, you are not only taking market risk on
each Underlying, you are also taking a risk relating to the relationship among the Underlyings.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">FOREIGN SECURITIES MARKETS RISK</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Some or all of the assets
included in the EURO STOXX 50<SUP>&reg;</SUP> Index and the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF (the &ldquo;Reference
Fund&rdquo;) are issued by foreign companies and trade in foreign securities markets. Investments in the securities therefore involve
risks associated with the securities markets in those countries, including risks of volatility in those markets, government intervention
in those markets and cross shareholdings in companies in certain countries. Also, foreign companies are generally subject to accounting,
auditing and financial reporting standards and requirements and securities trading rules different from those applicable to U.S. reporting
companies. The equity securities included in the EURO STOXX 50<SUP>&reg;</SUP> Index and the Reference Fund may be more volatile than
domestic equity securities and may be subject to different political, market, economic, exchange rate, regulatory and other risks, including
changes in foreign governments, economic and fiscal policies, currency exchange laws or other laws or restrictions. Moreover, the economies
of foreign countries may differ favorably or unfavorably from the economy of the United States in such respects as growth of gross national
product, rate of inflation, capital reinvestment, resources and self-sufficiency. These factors may adversely affect the values of the
equity securities included in the EURO STOXX 50<SUP>&reg;</SUP> Index and the Reference Fund, and therefore the performance of the EURO
STOXX 50<SUP>&reg;</SUP> Index and the Reference Fund, and the value of the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THERE ARE RISKS ASSOCIATED WITH THE REFERENCE FUND</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Although shares of the
Reference Fund are listed for trading on a national securities exchange and a number of exchange-traded funds generally have been traded
on various national securities exchanges for varying periods of time, there is no assurance that an active trading market will continue
for the shares of the Reference Fund or that there will be liquidity in the trading market. The Reference Fund is subject to management
risk, which is the risk that the Reference Fund&rsquo;s investment strategy, the implementation of which is subject to a number of constraints,
may not produce the intended results. Pursuant to the Reference Fund&rsquo;s investment strategy or otherwise, the investment advisor
for the Reference Fund may add, delete or substitute the assets held by the Reference Fund. Any of these actions could adversely affect
the price of the shares of the Reference Fund and consequently the value of the securities. For additional information about the Reference
Fund, see &ldquo;The Underlyings&mdash;The iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF&rdquo; herein.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THE PERFORMANCE AND MARKET VALUE OF THE REFERENCE
FUND, PARTICULARLY DURING PERIODS OF MARKET VOLATILITY, MAY NOT CORRELATE TO THE PERFORMANCE OF THE TRACKED INDEX</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The Reference Fund will
generally invest in all of the equity securities included in the index tracked by the Reference Fund (the &ldquo;Tracked Index&rdquo;),
but may not fully replicate the Tracked Index. There may be instances where the Reference Fund&rsquo;s investment advisor may choose to
overweight a stock in the Tracked Index, purchase securities not included in the Tracked Index that the investment advisor believes are
appropriate to substitute for a security included in the Tracked Index or utilize various combinations of other available investment techniques.
In addition, the performance of the Reference Fund will reflect additional transaction costs and fees that are not included in the calculation
of the Tracked Index. Finally, because the shares of the Reference Fund are traded on a national securities exchange and are subject to
market supply and investor demand, the market value of one share of the Reference Fund may differ from the net asset value per share of
the Reference Fund.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">During periods of market
volatility, securities held by the Reference Fund may be unavailable in the secondary market, market participants may be unable to calculate
accurately the net asset value per share of the Reference Fund and the liquidity of the Reference Fund may be adversely affected. This
kind of market volatility may also disrupt the ability of market participants to create and redeem shares in the Reference Fund. Further,
market volatility may adversely affect, sometimes materially, the prices at which market participants are willing to buy and sell shares
of the Reference Fund. As a result, under these circumstances, the market value of shares of the Reference Fund may vary substantially
from the net asset value per share of the Reference Fund. For these reasons, the performance of the Reference Fund may not correlate with
the performance of the Tracked Index. For additional information on the Reference Fund, see &ldquo;The Underlyings&mdash;The iShares<SUP>&reg;</SUP>
MSCI EAFE<SUP>&reg;</SUP> ETF&rdquo; herein.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">CURRENCY EXCHANGE RISK</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Because the prices of
the equity securities included in the Reference Fund are converted into U.S. dollars for purposes of calculating the level of the Reference
Fund, investors will be exposed to currency exchange rate risk with respect to each of the currencies in which the equity securities included
in the Reference Fund trade. Currency exchange rates may be highly volatile, particularly in relation to emerging or developing nations&rsquo;
currencies and, in certain market conditions, also in relation to developed nations&rsquo; currencies. Significant changes in currency
exchange rates, including changes in liquidity and prices, can occur within very short periods of time. Currency exchange rate risks include,
but are not limited to, convertibility risk, market volatility and potential interference by foreign governments through regulation of
local markets, foreign investment or particular transactions in foreign currency. These factors may adversely affect the values of the
equity securities included in the Reference Fund, the level of the Reference Fund and the value of the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THE CLOSING LEVEL OF THE EURO STOXX 50<SUP>&reg;</SUP>
INDEX WILL NOT BE ADJUSTED FOR CHANGES IN EXCHANGE RATES RELATIVE TO THE U.S. DOLLAR EVEN THOUGH THE EQUITY SECURITIES INCLUDED IN THE
EURO STOXX 50<SUP>&reg;</SUP> INDEX ARE TRADED IN A FOREIGN CURRENCY AND THE SECURITIES ARE DENOMINATED IN U.S. DOLLARS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The value of your securities
will not be adjusted for exchange rate fluctuations between the U.S. dollar and the currencies in which the equity securities included
in the EURO STOXX 50<SUP>&reg;</SUP> Index are based. Therefore, if the applicable currencies appreciate or depreciate relative to the
U.S. dollar over the term of the securities, you will not receive any additional payment or incur any reduction in your return, if any,
at maturity.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">NO OWNERSHIP RIGHTS RELATING TO THE UNDERLYINGS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Your return on the securities
will not reflect the return you would realize if you actually owned shares of the Reference Fund or the equity securities that comprise
the Underlyings. The return on your investment is not the same as the total return you would receive based on a purchase of shares of
the Reference Fund or the equity securities that comprise the Underlyings.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">NO VOTING RIGHTS OR DIVIDEND PAYMENTS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">As a holder of the
securities, you will not have voting rights or rights to receive cash dividends or other distributions or other rights with respect to
shares of the Reference Fund or the equity securities that comprise the Underlyings</FONT>.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">ANTI-DILUTION PROTECTION IS LIMITED</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The calculation agent
will make anti-dilution adjustments for certain events affecting the Reference Fund. However, an adjustment will not be required in response
to all events that could affect the Reference Fund. If an event occurs that does not require the calculation agent to make an adjustment,
or if an adjustment is made but such adjustment does not fully reflect the economics of such event, the value of the securities may be
materially and adversely affected. See &ldquo;Description of the Securities&mdash;Adjustments&rdquo; in the relevant product supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">GOVERNMENT REGULATORY ACTION, INCLUDING LEGISLATIVE
ACTS AND EXECUTIVE ORDERS, COULD RESULT IN MATERIAL CHANGES TO THE UNDERLYINGS AND COULD NEGATIVELY AFFECT YOUR RETURN ON THE SECURITIES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Government regulatory
action, including legislative acts and executive orders, could materially affect the Underlyings. For example, in response to recent executive
orders, stocks of companies that are determined to be linked to the People&rsquo;s Republic of China military, intelligence and security
apparatus may be delisted from a U.S. exchange, removed as a component in indices or exchange traded funds, or transactions in, or holdings
of, securities with exposure to such stocks may otherwise become prohibited under U.S. law. If government regulatory action results in
such consequences, there may be a material and negative effect on the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Issuer</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">CREDIT SUISSE IS SUBJECT TO SWISS REGULATION</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">As a Swiss bank, Credit
Suisse is subject to regulation by governmental agencies, supervisory authorities and self-regulatory organizations in Switzerland. Such
regulation is increasingly more extensive and complex and subjects Credit Suisse to risks. For example, pursuant to Swiss banking laws,
the Swiss Financial Market Supervisory Authority (FINMA) may open resolution proceedings if there are justified concerns that Credit Suisse
is over-indebted, has serious liquidity problems or no longer fulfills capital adequacy requirements. FINMA has broad powers and discretion
in the case of resolution proceedings, which include the power to convert debt instruments and other liabilities of Credit Suisse into
equity and/or cancel such liabilities in whole or in part. If one or more of these measures were imposed, such measures may adversely
affect the terms and market value of the securities and/or the ability of Credit Suisse to make payments thereunder and you may not receive
any amounts owed to you under the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to Conflicts of Interest</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">HEDGING AND TRADING ACTIVITY</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">We or any of our affiliates
may carry out hedging activities related to the securities, including in the Reference Fund or instruments related to the Underlyings.
We or our affiliates may also trade in the Reference Fund or instruments related to the Underlyings from time to time. Any of these hedging
or trading activities on or prior to the Trade Date and during the term of the securities could adversely affect our payment to you at
maturity.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">POTENTIAL CONFLICTS</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">We and our affiliates
play a variety of roles in connection with the issuance of the securities, including acting as calculation agent and as agent of the issuer
for the offering of the securities, hedging our obligations under the securities and determining their estimated value. In performing
these duties, the economic interests of us and our affiliates are potentially adverse to your interests as an investor in the securities.
Further, hedging activities may adversely affect any payment on or the value of the securities. Any profit in connection with such hedging
activities will be in addition to any other compensation that we and our affiliates receive for the sale of the securities, which creates
an additional incentive to sell the securities to you.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><I>Risks Relating to the Estimated Value and Secondary
Market Prices of the Securities</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">UNPREDICTABLE ECONOMIC AND MARKET FACTORS WILL AFFECT
THE VALUE OF THE SECURITIES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The payout on the securities
can be replicated using a combination of the components described in &ldquo;The estimated value of the securities on the Trade Date is
less than the Price to Public.&rdquo; Therefore, in addition to the levels of the Underlyings, the terms of the securities at issuance
and the value of the securities prior to maturity may be influenced by factors that impact the value of fixed income securities and options
in general, such as:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the expected and actual volatility of the Underlyings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the expected and actual correlation, if any, between the Underlyings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the dividend rate on the equity securities included in the Underlyings;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">investors&rsquo; expectations with respect to the rate of inflation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">geopolitical conditions and economic, financial, political, regulatory, judicial
or other events that affect the components included in the Underlyings or markets generally and which may affect the levels of the Underlyings;
and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">our creditworthiness, including actual or anticipated downgrades
in our credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.75in">Some or all of these factors may influence the price that
you will receive if you choose to sell your securities prior to maturity. The impact of any of the factors set forth above may enhance
or offset some or all of any change resulting from another factor or factors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 1.75in">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">THE ESTIMATED VALUE OF THE SECURITIES ON THE TRADE
DATE IS LESS THAN THE PRICE TO PUBLIC</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The initial estimated
value of your securities on the Trade Date (as determined by reference to our pricing models and our internal funding rate) is less than
the original Price to Public. The Price to Public of the securities includes any discounts or commissions as well as transaction costs
such as expenses incurred to create, document and market the securities and the cost of hedging our risks as issuer of the securities
through one or more of our affiliates (which includes a projected profit). These costs will be effectively borne by you as an investor
in the securities. These amounts will be retained by Credit Suisse or our affiliates in connection with our structuring and offering of
the securities (except to the extent discounts or commissions are reallowed to other broker-dealers or any costs are paid to third parties).</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">On the Trade Date, we
value the components of the securities in accordance with our pricing models. These include a fixed income component valued using our
internal funding rate, and individual option components valued using proprietary pricing models dependent on inputs such as volatility,
correlation, dividend rates, interest rates and other factors, including assumptions about future market events and/or environments. These
inputs may be market-observable or may be based on assumptions made by us in our discretionary judgment. As such, the payout on the securities
can be replicated using a combination of these components and the value of these components, as determined by us using our pricing models,
will impact the terms of the securities at issuance. Our option valuation models are proprietary. Our pricing models take into account
factors such as interest rates, volatility and time to maturity of the securities, and they rely in part on certain assumptions about
future events, which may prove to be incorrect.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">Because Credit Suisse&rsquo;s
pricing models may differ from other issuers&rsquo; valuation models, and because funding rates taken into account by other issuers may
vary materially from the rates used by Credit Suisse (even among issuers with similar creditworthiness), our estimated value at any time
may not be comparable to estimated values of similar securities of other issuers.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">EFFECT OF INTEREST RATE USED IN STRUCTURING THE SECURITIES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The internal funding
rate we use in structuring notes such as these securities is typically lower than the interest rate that is reflected in the yield on
our conventional debt securities of similar maturity in the secondary market (our &ldquo;secondary market credit spreads&rdquo;). If on
the Trade Date our internal funding rate is lower than our secondary market credit spreads, we expect that the economic terms of the securities
will generally be less favorable to you than they would have been if our secondary market credit spread had been used in structuring the
securities. We will also use our internal funding rate to determine the </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">price of the securities
if we post a bid to repurchase your securities in secondary market transactions. See &ldquo;&mdash;Secondary Market Prices&rdquo; below.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">SECONDARY MARKET PRICES</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">If Credit Suisse (or
an affiliate) bids for your securities in secondary market transactions, which we are not obligated to do, the secondary market price
(and the value used for account statements or otherwise) may be higher or lower than the Price to Public and the estimated value of the
securities on the Trade Date. The estimated value of the securities on the cover of this pricing supplement does not represent a minimum
price at which we would be willing to buy the securities in the secondary market (if any exists) at any time. The secondary market price
of your securities at any time cannot be predicted and will reflect the then-current estimated value determined by reference to our pricing
models, the related inputs and other factors, including our internal funding rate, customary bid and ask spreads and other transaction
costs, changes in market conditions and deterioration or improvement in our creditworthiness. In circumstances where our internal funding
rate is higher than our secondary market credit spreads, our secondary market bid for your securities could be less favorable than what
other dealers might bid because, assuming all else equal, we use the higher internal funding rate to price the securities and other dealers
might use the lower secondary market credit spread to price them. Furthermore, assuming no change in market conditions from the Trade
Date, the secondary market price of your securities will be lower than the Price to Public because it will not include any discounts or
commissions and hedging and other transaction costs. If you sell your securities to a dealer in a secondary market transaction, the dealer
may impose an additional discount or commission, and as a result the price you receive on your securities may be lower than the price
at which we may repurchase the securities from such dealer.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">We (or an affiliate)
may initially post a bid to repurchase the securities from you at a price that will exceed the then-current estimated value of the securities.
That higher price reflects our projected profit and costs, which may include discounts and commissions that were included in the Price
to Public, and that higher price may also be initially used for account statements or otherwise. We (or our affiliate) may offer to pay
this higher price, for your benefit, but the amount of any excess over the then-current estimated value will be temporary and is expected
to decline over a period of approximately three months. </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The securities are not
designed to be short-term trading instruments and any sale prior to maturity could result in a substantial loss to you. You should be
willing and able to hold your securities to maturity.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">LACK OF LIQUIDITY</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">The securities will not
be listed on any securities exchange. Credit Suisse (or its affiliates) intends to offer to purchase the securities in the secondary market
but is not required to do so. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the
securities when you wish to do so. Because other dealers are not likely to make a secondary market for the securities, the price at which
you may be able to trade your securities is likely to depend on the price, if any, at which Credit Suisse (or its affiliates) is willing
to buy the securities. If you have to sell your securities prior to maturity, you may not be able to do so or you may have to sell them
at a substantial loss.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Supplemental Use of Proceeds and Hedging</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We intend to use the proceeds of this offering for our
general corporate purposes, which may include the refinancing of existing debt outside Switzerland. Some or all of the proceeds we receive
from the sale of the securities may be used in connection with hedging our obligations under the securities through one or more of our
affiliates. Such hedging or trading activities on or prior to the Trade Date and during the term of the securities (including on any calculation
date, as defined in any accompanying product supplement) could adversely affect the value of the Underlyings and, as a result, could decrease
the amount you may receive on the securities at maturity. For additional information, see &ldquo;Supplemental Use of Proceeds and Hedging&rdquo;
in any accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">The Underlyings</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>The iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP>
ETF</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We have derived all information contained herein regarding
the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF from publicly available information. Such information reflects the policies
of, and is subject to change by, BlackRock Fund Advisors, which maintains and manages the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP>
ETF and acts as investment advisor to the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF. We have not conducted any independent
review or due diligence of any publicly available information with respect to the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF
is an exchange-traded fund that seeks to track the investment results of the MSCI EAFE<SUP>&reg;</SUP> Index, which is composed of large-
and mid-capitalization developed market equities, excluding the U.S. and Canada.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The iShares<SUP>&reg;</SUP> Trust is a registered investment
company that consists of numerous separate investment portfolios, including the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF.
Information filed by the iShares<SUP>&reg;</SUP> Trust with the SEC under the Securities Act and the Investment Company Act can be found
by reference to its SEC file numbers: 333-92935 and 811-09729. Shares of the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP> ETF are
listed on the NYSE Arca under ticker symbol &ldquo;EFA.&rdquo; Information from outside sources is not incorporated by reference in, and
should not be considered part of, this pricing supplement or the accompanying underlying supplement, any accompanying product supplement,
the prospectus supplement and the prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The EURO STOXX 50<SUP>&reg;</SUP> Index</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="font-weight: normal">For more information
on the EURO STOXX 50<SUP>&reg;</SUP> Index, see &ldquo;The Reference Indices&mdash;The STOXX Indices&mdash;The EURO STOXX 50<SUP>&reg;</SUP>
Index&rdquo; in the accompanying underlying supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Historical Information</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The following graphs set forth the historical performance
of the Underlyings based on the closing levels of such Underlyings from January 3, 2017 through August 26, 2022. We obtained the historical
information below from Bloomberg, without independent verification. The closing levels reported by Bloomberg may not be the same as the
closing levels derived from the applicable Reuters page.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">You should not take the historical levels of the Underlyings
as an indication of future performance of the Underlyings or the securities. Any historical trend in the levels of the Underlyings during
any period set forth below is not an indication that the levels of the Underlyings are more or less likely to increase or decrease at
any time over the term of the securities. The graphs below may have been adjusted to reflect certain corporate actions such as stock splits
and reverse stock splits.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">For additional information on the Underlyings, see &ldquo;The
Underlyings&rdquo; herein.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; margin-left: 127.45pt">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-top: Black 1pt solid; width: 100%"><P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing level of the iShares<SUP>&reg;</SUP> MSCI EAFE<SUP>&reg;</SUP>
ETF on August 26, 2022 was $62.71.</P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 301px; width: 562px"></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<p>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; margin-left: 127.45pt">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-top: Black 1pt solid; width: 100%"><P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing level of the EURO STOXX 50<SUP>&reg;</SUP> Index on
August 26, 2022 was 3603.68.</P></TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_003.gif" ALT="" STYLE="height: 302px; width: 544px"></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">United States Federal Tax Considerations</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">This discussion supplements and, to the extent inconsistent
therewith, supersedes the discussion in the accompanying product supplement under &ldquo;United States Federal Tax Considerations.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">There are no statutory, judicial or administrative authorities
that address the U.S. federal income tax treatment of the securities or instruments that are similar to the securities. In the opinion
of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions, a security should be treated as a prepaid
financial contract that is an &ldquo;open transaction&rdquo; for U.S. federal income tax purposes. However, there is uncertainty regarding
this treatment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Assuming this treatment of the securities is respected
and subject to the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following
U.S. federal income tax consequences should result:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>You should not recognize taxable income over the term of the securities prior to maturity, other than pursuant to a sale or other
disposition.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 145.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or other disposition (including retirement) of a security, you should recognize gain or loss equal to the difference between
the amount realized and your tax basis in the security. Subject to the discussion below concerning the potential application of the &ldquo;constructive
ownership&rdquo; rules under Section 1260 of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), such gain or loss
should be long-term capital gain or loss if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Even if the treatment of the securities as described herein
is respected, there is a substantial risk that your purchase of a security will be treated as entry into a &ldquo;constructive ownership
transaction,&rdquo; within the meaning of Section 1260 of the Code. In that case, all or a portion of any long-term capital gain you would
otherwise recognize in respect of your securities would be recharacterized as ordinary income to the extent such gain exceeded the &ldquo;net
underlying long-term capital gain.&rdquo; Any long-term capital gain recharacterized as ordinary income under Section 1260 would be treated
as accruing at a constant rate over the period you held your securities, and you would be subject to an interest charge in respect of
the deemed tax liability on the income treated as accruing in prior tax years. Due to the lack of governing authority under Section 1260,
our counsel is not able to opine as to whether or how Section 1260 applies to the securities. You should read the section entitled &ldquo;United
States Federal Tax Considerations&mdash;Tax Consequences to U.S. Holders&mdash;Securities Treated as Prepaid Financial Contracts that
are Open Transactions&mdash;Possible Application of Section 1260 of the Code&rdquo; in the accompanying product supplement for additional
information and consult your tax advisor regarding the potential application of the &ldquo;constructive ownership&rdquo; rule.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We do not plan to request a ruling from the IRS regarding
the treatment of the securities, and the IRS or a court might not agree with the treatment described herein. In particular, the IRS could
treat the securities as contingent payment debt instruments, in which case the tax consequences of ownership and disposition of the securities,
including the timing and character of income recognized, could be materially and adversely affected. Moreover, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
In addition, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>Non-U.S. Holders</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Subject to the discussions in the next paragraph and in
&ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo; and &ldquo;United States Federal Tax
Considerations&mdash;FATCA&rdquo; in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying
product supplement) of the securities, you generally should not be subject to U.S. federal withholding or income tax in respect of any
amount paid to you with respect to the securities, provided that (i) income in respect of the securities is not effectively connected
with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&mdash;Dividend Equivalents under Section 871(m) of the Code&rdquo; in the accompanying product supplement,
Section 871(m) of the Internal Revenue Code generally imposes a 30% withholding tax on &ldquo;dividend equivalents&rdquo; paid or deemed
paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities.
Treasury regulations under Section 871(m), as modified by an IRS notice, exclude from their scope financial instruments issued prior to
January 1, 2025 that do not have a &ldquo;delta&rdquo; of one with respect to any U.S. equity. Based on the terms of the securities and
representations provided by us, our counsel is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo;
of one within the meaning of the regulations with respect to any U.S. equity and, therefore, should not be subject to withholding tax
under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">A determination that the securities are not subject to
Section 871(m) is not binding on the IRS, and the IRS may disagree with this determination. Moreover, Section 871(m) is complex and its
application may depend on your particular circumstances, including your other transactions. You should consult your tax advisor regarding
the potential application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">If withholding tax applies to the securities, we will not
be required to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>You should read the section entitled &ldquo;United States
Federal Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the securities. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><B>You should also consult your tax advisor regarding all
aspects of the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Supplemental Plan of Distribution
(Conflicts of Interest)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">Under the terms and subject to the conditions contained
in a distribution agreement dated May 7, 2007, as amended, which we refer to as the distribution agreement, we have agreed to sell the
securities to CSSU.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The distribution agreement provides that CSSU is obligated
to purchase all of the securities if any are purchased.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">CSSU will offer the securities at the offering price set
forth on the cover page of this pricing supplement and will receive discounts and commissions of $38.50 per $1,000 principal amount of
securities. CSSU may re-allow some or all of the discount on the principal amount per security on sales of such securities by other brokers
or dealers. CSSU or another broker or dealer will forgo some or all discounts and commissions with respect to the sales of securities
into certain fiduciary accounts. If all of the securities are not sold at the initial offering price, CSSU may change the public offering
price and other selling terms.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">An affiliate of Credit Suisse has paid or may pay in the
future a fixed amount to broker-dealers in connection with the costs of implementing systems to support these securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">We expect to deliver the securities against payment for
the securities on the Settlement Date indicated herein, which may be a date that is greater than two business days following the Trade
Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle
in two business days, unless the parties to a trade expressly agree otherwise. Accordingly, if the Settlement Date is more than two business
days after the Trade Date, purchasers who wish to transact in the securities more than two business days prior to the Settlement Date
will be required to specify alternative settlement arrangements to prevent a failed settlement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">The agent for this offering, CSSU, is our affiliate. In
accordance with FINRA Rule 5121, CSSU may not make sales in this offering to any of its discretionary accounts without the prior written
approval of the customer. A portion of the net proceeds from the sale of the securities will be used by CSSU or one of its affiliates
in connection with hedging our obligations under the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">For further information, please refer to &ldquo;Underwriting
(Conflicts of Interest)&rdquo; in any accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 24pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal; background-color: white">Validity
of the Securities</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt"><FONT STYLE="background-color: white">In the opinion of
Davis Polk &amp; Wardwell LLP, as United States counsel to Credit Suisse, when the securities offered by this pricing supplement have
been executed and issued by Credit Suisse and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities will be valid and binding obligations of Credit Suisse, enforceable against Credit Suisse in accordance with their terms,
subject to (i) applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo; rights generally, (ii) concepts of reasonableness
and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of
bad faith) and (iii) possible judicial or regulatory actions or application giving effect to governmental actions or foreign laws affecting
creditors&rsquo; rights, provided that such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer
or similar provision of applicable law on the conclusions expressed above. This opinion is given as of the date of this pricing supplement
and is limited to the laws of the State of New York, except that such counsel expresses no opinion as to the application of state securities
or Blue Sky laws to the securities. Insofar as this opinion involves matters governed by Swiss law, Davis Polk &amp; Wardwell LLP has
relied, without independent inquiry or investigation, on the opinion of Homburger AG, dated August 12, 2022 and filed by Credit Suisse
as an exhibit to a Current Report on Form 6-K on August 12, 2022. The opinion of Davis Polk &amp; Wardwell LLP is subject to the same
assumptions, qualifications and limitations with respect to such matters as are contained in the opinion of Homburger AG. In addition,
the opinion of Davis Polk &amp; Wardwell LLP is subject to customary assumptions about the establishment of the terms of the securities,
the trustee&rsquo;s authorization, execution and delivery of the indenture and its authentication of the securities, and the validity,
binding nature and enforceability of the indenture with respect to the trustee, all as stated in the opinion of Davis Polk &amp; Wardwell
LLP dated August 12, 2022, which was filed by Credit Suisse as an exhibit to a Current Report on Form 6-K on August 12, 2022. Davis Polk
&amp; Wardwell LLP expresses no opinion as to waivers of objections to venue, the subject matter or personal jurisdiction of a United
States federal court or the effectiveness of service of process other than in accordance with applicable law. In addition, such counsel
notes that the enforceability in the United States of Section 10.08(c) of the indenture is subject to the limitations set forth in the
United States Foreign Sovereign Immunities Act of 1976.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 127.45pt">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Buffered Accelerated Return Equity Securities</FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<p>&nbsp;</P>

<P>&nbsp;</P>

<P>&nbsp;</P>

<P>&nbsp;</P>

<P>&nbsp;</P>

<P>&nbsp;</P>

<P>&nbsp;</p>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 59px; width: 229px"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>CREDIT SUISSE SECURITIES (USA) LLC</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">credit-suisse.com</P>
    <P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Copyright &copy; 2022 Credit Suisse Group AG and/or its affiliates. All rights reserved.&nbsp;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: right; width: 91%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></TD><TD STYLE="text-align: right; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp179409_exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Exhibit
107.1</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-size: 10pt">The pricing supplement
to which this Exhibit is attached is a final prospectus for the related offering. The maximum aggregate offering price of that offering
is $554,000.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ^ 0D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@##\0ZCJ>BVS:E:V@O[6(9N+9?EE5>[(>AQU*G\".E-\.>,M$\4P[M-O%,P&
M7MY/EE7_ (#W^HR*WJ^>/B?X5D\)^(X]5TO?!9W;&2-HB5,,O5E!'3U'XCM6
MM.,9^Z]S.<G'7H?0<\;30NBRO$Q'#IU4]CSQ^=<[I7BQ'UN3P]K 2UUB/E!T
MCND[/&3Z_P!WJ,'K@UYGX1^,MU:&.S\1JUS!T%V@_>+_ +PZ-]>OUKH_B;I]
MEXG\'1>)='N$GEL#YB3PMR8\_,/8J<'GD8/K3]DXRY9=1>T35XGI]%>4_#CX
MH#5&AT7790M[@+!=,<"8_P!UO1O0]_KU]6K.<'!V9<9*2N@HHHJ2@HHI&944
MLQ"@=23B@!:*@CO;65PD=S"['LL@)J>@ HHHH **** "BBB@ HHHH **** "
MBBB@ HJ*6ZM[<@33Q1D] [@9_.I%974,K!E/((.0: %HHHH **** "BBB@ H
MHHH *P?&/A]/$WA>\TT@><R;X&/\,B\K_@?8FMZBFG9W0FKJQ\;NC1NR.I5U
M)#*PP0?0UI:/X@U#1#.MI,?(N(VBN+=^8Y5(P0R_3OUKH?BIH@T;QU=M&FV"
M] NDP.,M][_QX,?Q%<=;B%KF);AF2$N!(RC)"YY('KBO334HW.!IQE8Z+Q9X
M)U7PE.CSH9;*3F&[C'RGV/\ =;V_+->I?"[XB?VQ%'H6KS9U!%Q!,YYG4=C_
M +0'YCWZR2_%WP9J=K+87ME?&U==C+-;JR,/H&)KRG7;#2;?4DOO"6IM<0>8
M'CA(9)[=AR,9 + =F&<8Y]3AK4CRS5GW-M(.\'H?4E%<?\//&2>+M!W3%5U&
MVPER@XW>C@>A_0@UV%<<HN+LSI335T<]XR\56_A'0)-0E423,?+MX<XWN?Z#
MJ:X;P[X1U+Q]"FO^,;ZX>UF^>VL(G*)M[,1V'ICD]2:R/C?=/-XCTC3G<I E
MOYFX_=!=RI/X!!7ML$,=O;QP1*%CC4(BCL , 5K\$$UNS/XI-/9'&W'PG\'3
M6_EQZ:]NX&%EBN)-R^_)(/X@U7\$Z?K?A[Q-J>AZEJ-Q?60@6>RDE8M\NX@]
M>A'&1T[]Z[ZC SG'-1SR:L]2^1)W1QDGQ1\-1WL]F9+PW$#LDB+:NQ4J<'H/
M6M7P_P",M"\3EUTJ^665!EHG4HX'K@]1[BO-/ <\-O\ &?Q4\TJ1KF[&YV &
M?M"^M)!]GUGX[QW?AT*UM 0]U/"/W9(0ASD<<Y"Y[GGFM73CJO*YFIO?S/5]
M>UZQ\-Z:=0U$R+;!PC,B%L$],@5SH^*GAHQ>:&OC'C=O^QOC'KG%-^+?_).-
M1_WX?_1BU7\$>,O#EOX/TBQGU>UCN8X%B>)VPP;TQ4**Y.:URG)\UCIY?$VG
M0^&!XA9I3IYC67<L9+;2<9V]>]<__P +9\+>3YWG7GE=-_V1]OYXK1\;00VO
MP[UF&"-8XDM'"HHP!]!65\'_ /DGEK_UVE_]"I*,>7F?<;;YK&_H/C+0/$C&
M/2]1CEF R86!1\>NUL$CW%6=>U^Q\-Z;_:&HM(ML'"%HXR^">F<=O_K5Y[\6
M/#<.FVD'BS2%%EJ%K,OFR0#;O!. QQW!P/<$YSQ5CQGK'_"0?!'^U"%#W"0,
MX7H'$BA@/^! TU!.S6S%SM73W1U=UXXT2ST&QUJ66;['>OY<!6$LS-SQM'/\
M)K+D^*WA>)U222]1W^ZK6C@GZ<5:^'EO#-X!T"26)'>&,M&S#)0Y89'H<$C\
M:X_XKL4\<>$G7JLH(_[^)3C&+ER^H2DU&YVNE_$#0M7U>WTNV:Z6ZN-WEK+;
M,@.U2QY(] :D\>:_/X;\'WNHVH!N1MCB)Z*S$#=^&2?PKH'@BEDBDDC5GB8M
M&Q&2A((R/3@D?C6=XCT*W\2Z#=:5=,52=1AUZHP.5;\"!4)QYEV*:=F<+X+\
M":)K_AF'6=<5]5O]04R2SRS/E>2-HP1R,<^];GA'PC+X1\0:G!:S32:-<1))
M DCY\I\MN7^7/<8SG%>8(WC7X47;+L\_2V?.2"]N_/7/5&/X?C7JW@SQ_IGC
M*)HX5:VOXEW2VKG)Q_>4_P 0S]#[=*UJ*=FT[IF<'&Z35F76\8Z0GBE?#CO,
MNI,<*AB.T_+NR&Z8Q6[)((HGD()"J6('4XKR'4?^3B;#_KF/_1+5ZY<?\>TO
M^X?Y5E.*5K=4:1DW<SM-\1:?JV@'6[-I)+,*[9\LAB$SG"]>QJ/P[XITOQ5:
MS7&ERR21POL<O&5YQGO7._"S_DE]G_VW_P#0VK%^!?\ R+VJ?]?8_P#0!5."
M2EY$J3;7F=KK?C/1]!O([&XDFFOI!N6UM8C+)CUP.GXT:!XTT?Q'>365F\\=
M[ N^2WN(6C=5R!GGCN/SKS0>(5\#_%S6KG7+61X;[_5W"IEDC)!4KZK@ '']
MWVQ7J&FC1-;U&+Q)IEQ%/*+=K8RPD?,A*MAQC.05& <8R:)045^H1DVQNO>+
M]'\.S0V][-(]W-S';6\9DD8>NT=OK4.A^-]&U[49-.MVN8;Y%WFWN8&C?;Z\
M\=Q7G&L:TW@SXSW>K:Q:S36ES"$@D49VH54;E]<$$$>YKTW39]!\2W=KK^FW
M,5Q-!&T0DC.&"M@E7'4= <'&/QHE!128*3;L5=;\?:%X?U;^S-0>Y6Z*JZJD
M#/N!Z$8Z]Q^%167Q%T"^U&VL8FO%GN9!'$)+5T!8^Y%<)X[O+?3_ (TZ'>7<
MHBMX886D=NBC>_->FV.O^'O$5P+:SO[2]FBQ.$1MQ3:1AO;!(_.AP2BG8%)M
MM7.:^)G@6\\8_P!FOISP1SV[.LC3,0NQL>@)X(_4US%I\!S@&\U\9QRL-MW^
MI;^E>S44E5G%63&Z<6[L\G?X%:64 36;P-ZF-2/RK*NO@9J-O^\TW78))5.Y
M/-B:+!^H+<U[;135>HNHG2AV.&\(:/J%M?B77M)2WU>%"O\ :5HR[+Q#QB3'
M5N ?F'8$5W-%%9R=W<M*RL>5?&KPW/J&EVNMVL9<V09)U49/EG!#?0'.?KGM
M76^ _%-OXI\-6\XD7[;"@CNH^ZN!UQZ'J/\ ZU=.RJZE6 *D8((X(KS_ %#X
M5VL>IG4_#6J7.AW1.2L(W1^X"Y! ]LX]JT4E*/++H0XM2YD>@UAV_B2"\\83
MZ#;!9/LMJ9KB4-]QRRA4QZX))].*YT^$O&]U'Y%YXZ98#PQ@LE5R.^&&"#[Y
MK:\*>"-*\(K,]EYTMU.,37$[[F?G.,=!^7US4VBEO<J[;V/*_#/A_3/$GQ;\
M4V6K6WVB!7NY%7>RX87"@'*D'H35[PS=S?#7XA7'AR^D/]DWS PRN.F>$?\
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MR6'][IBF7/@?Q/J$7V?4/'4\]HQ EA6P6/S%[J2K9P1Q1)J26HU=-Z'>T4
1# & **Q- HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %! DL# 2(  A$! Q$!_\0
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MD:TDU!EAAN%(;[/N^12#S]W'X5VVLVD-C\9?#MKI]O#;QQZ5*L442!$3EL
M<"@#TO[;:?:?LWVJ'[1_SR\P;ORZTDU]9VTJQ3W4$4C_ '4>0*3] :\(T%?"
M4&@J_B"RN)O%JZDS2):*/M[2^8<, Q#;/TK+\>R6NIZEXOEFCTZTNX)-B1WD
M+37DP4<-$2P"+QU ./6@#V_4O%G]G^-]*\-_8O,_M"%Y?M'FX\O;GC;CGIZB
MJ7C3QK>^&+[2['3M"_M:[U&0QQQ?:U@P?JRD?RKD893-\1/A_(7WEM)8[LYS
M\IJU\4K:]O/&'A"#3M0_L^[>Y(CN?)67RSZ[6X- &]X8\>WFK^)+CP_K7AV;
M1=2BC\T1M<K.KK[,H _+-=A#>VMS(\<%S#*Z?>5) Q7Z@=*\UO\ P'J^DZ1K
M^NR:[=:UXEFLGCBG$"PA!MZ(BYP?I7#^!+4+XI\*G3)-*$Z)_I*Z9:N)%3'S
M"Y9G.&Z]LYH ]XNM=TNTMY9I+^UQ&K,0)ER<=0.:Q?!7C%_%^D/JKV=K9VF3
ML O/-D '=UV +^9K@/A[X;T:[\+^)]0N],M+FZ:>X7S)H5=@!NX!(.*P;+3H
MT^#^A2K9@:;+J*'5S!%AI(0_.XJ,D#WH ^@8KRUG@:>&YADB7.Z1) 5'XBHA
MJVG'IJ%J>AXF7OT[UXVL6F#Q-XCD\(1P+H9T247;6B_Z.TFPXVD?+NSUQ[UF
MW.@Z99_ :SG@LH([B[E@\^94 DDS(O!;K0![P=3L CN;ZVV(<,WFKA3Z'GBI
M)KNVMX?.GN(HHC_&[A5_,UX-<>$]!_X3/Q3;#2K46]MH!GAA$8V))M^^!_>Y
MZU6DNH+K1O!5A?I81P_9W9;O5D:6V4A3\OEY4,_ID_A0!] F\M5@6<W,(A;
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MX#I_A1_8>D?] NR_\!T_PH OT50_L/2/^@79?^ Z?X4?V'I'_0+LO_ =/\*
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M7HK(V>(O^>^E_P#?F3_XJC9XB_Y[Z7_WYD_^*H UZ*R-GB+_ )[Z7_WYD_\
MBJ-GB+_GOI?_ 'YD_P#BJ ->BLC9XB_Y[Z7_ -^9/_BJ-GB+_GOI?_?F3_XJ
M@#7HK(V>(O\ GOI?_?F3_P"*HV>(O^>^E_\ ?F3_ .*H UZ*R-GB+_GOI?\
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M -^9/_BJ-GB+_GOI?_?F3_XJ@#7HK(V>(O\ GOI?_?F3_P"*HV>(O^>^E_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"/PS6A_;FD?]!2R_\"$_QH OT50_MS2/^@I9?^!"?XT?VYI'_04LO_ A/\:
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MT()ZU9.NZ..NJV/_ ($)_C4--.S*33U-"BJ']N:1_P!!2R_\"$_QH_MS2/\
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M3[B"87%S-]FB,,"RE<1(3D@;5!/;KGI6G<_\>LW^X?Y5+45S_P >LW^X?Y4
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M)+B/<+F=MZJ#T.X<=.Q&:N--RU)E-+0ZBT\1:/?7+VUOJ,#3HYC,9;:VX=0
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MMC(_LS5?^@_/_P" T7_Q-']F:K_T'Y__  &B_P#B:UZ*0S(_LS5?^@_/_P"
MT7_Q-']F:K_T'Y__  &B_P#B:UZ* ,C^S-5_Z#\__@-%_P#$T?V9JO\ T'Y_
M_ :+_P")K7HH R/[,U7_ *#\_P#X#1?_ !-']F:K_P!!^?\ \!HO_B:UZ* ,
MC^S-5_Z#\_\ X#1?_$T?V9JO_0?G_P# :+_XFM>B@#(_LS5?^@_/_P" T7_Q
M-']F:K_T'Y__  &B_P#B:UZ* ,C^S-5_Z#\__@-%_P#$T?V9JO\ T'Y__ :+
M_P")K7HH R/[,U7_ *#\_P#X#1?_ !-']F:K_P!!^?\ \!HO_B:UZ* .>U#P
MU<ZI L%[K$LT0=7V-;18)!R,C'(]JD?0+N1HF?5BS1?ZLM9PDI]/EXK=HIW8
MK(\MU2WU#P+?_P#$NN[RX%^"$C2-#F7(P,$''&>@K<T?P7(@34KB]<:C+B21
MIK>-V1O;<#M_#%=A/:6]TT33PK(87\R,L,[6QC(_.IJTE5;7GU(4+/R,C^S-
M5_Z#\_\ X#1?_$T?V9JO_0?G_P# :+_XFM>BLC0R/[,U7_H/S_\ @-%_\31_
M9FJ_]!^?_P !HO\ XFM>B@#(_LS5?^@_/_X#1?\ Q-(VE:FZ%'UV9E88(-M$
M01_WS6Q10!BQ:/J$$2QPZW)'&O 5+6$ ?@%I_P#9FJ_]!^?_ ,!HO_B:UZ*
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MB@#(_LS5?^@_/_X#1?\ Q-']F:K_ -!^?_P&B_\ B:UZ* ,C^S-5_P"@_/\
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MJS= _P"0#9_]<ZTJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /@++_\ $U+H'_(!L_\ KG6E0!D?\)-I7_/6?_P%E_\ B:/^$FTK_GK/_P"
MLO\ \36O10!D?\)-I7_/6?\ \!9?_B:/^$FTK_GK/_X"R_\ Q-:]% &1_P )
M-I7_ #UG_P# 67_XFC_A)M*_YZS_ /@++_\ $UKT4 9'_"3:5_SUG_\  67_
M .)H_P"$FTK_ )ZS_P#@++_\36O10!D?\)-I7_/6?_P%E_\ B:/^$FTK_GK/
M_P" LO\ \36O10!D?\)-I7_/6?\ \!9?_B:/^$FTK_GK/_X"R_\ Q-:]% &1
M_P )-I7_ #UG_P# 67_XFC_A)M*_YZS_ /@++_\ $UKT4 9'_"3:5_SUG_\
M 67_ .)H_P"$FTK_ )ZS_P#@++_\36O10!D?\)-I7_/6?_P%E_\ B:/^$FTK
M_GK/_P" LO\ \36O10!D?\)-I7_/6?\ \!9?_B:/^$FTK_GK/_X"R_\ Q-:]
M% &1_P )-I7_ #UG_P# 67_XFC_A)M*_YZS_ /@++_\ $UKT4 9'_"3:5_SU
MG_\  67_ .)H_P"$FTK_ )ZS_P#@++_\36O10!D?\)-I7_/6?_P%E_\ B:/^
M$FTK_GK/_P" LO\ \36O10!D?\)-I7_/6?\ \!9?_B:/^$FTK_GK/_X"R_\
MQ-:]% &1_P )-I7_ #UG_P# 67_XFC_A)M*_YZS_ /@++_\ $UKT4 9'_"3:
M5_SUG_\  67_ .)H_P"$FTK_ )ZS_P#@++_\36O10!D?\)-I7_/6?_P%E_\
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MK_GK/_X"R_\ Q-:]% &1_P )-I7_ #UG_P# 67_XFC_A)M*_YZS_ /@++_\
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M%_\ J.ZW_P"!?_UJ -ZBL'_A%_\ J.ZW_P"!?_UJ/^$7_P"H[K?_ (%__6H
MWJ*P?^$7_P"H[K?_ (%__6H_X1?_ *CNM_\ @7_]:@#>HK!_X1?_ *CNM_\
M@7_]:C_A%_\ J.ZW_P"!?_UJ -ZBL'_A%_\ J.ZW_P"!?_UJ/^$7_P"H[K?_
M (%__6H WJ*P?^$7_P"H[K?_ (%__6H_X1?_ *CNM_\ @7_]:@#>HK!_X1?_
M *CNM_\ @7_]:C_A%_\ J.ZW_P"!?_UJ -ZBL'_A%_\ J.ZW_P"!?_UJ/^$7
M_P"H[K?_ (%__6H WJ*P?^$7_P"H[K?_ (%__6H_X1?_ *CNM_\ @7_]:@#>
MHK!_X1?_ *CNM_\ @7_]:C_A%_\ J.ZW_P"!?_UJ -ZBL'_A%_\ J.ZW_P"!
M?_UJ/^$7_P"H[K?_ (%__6H WJ*P?^$7_P"H[K?_ (%__6H_X1?_ *CNM_\
M@7_]:@#>HK!_X1?_ *CNM_\ @7_]:C_A%_\ J.ZW_P"!?_UJ -ZBL'_A%_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%P+<Z1J?FE=P3RTSCU^_0!MT5D?VY+_T!=4_[]I_\71_;DO_ $!=4_[]I_\
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MJK(P#*<GN!6S7$7DNAZG/87=[!?VVIV]W!&T3;$FW;UV^8%)5DS@Y&?:NWH
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M.8H>/[S!6_E0!4\(PZ;=7%WKD7E)J5X2MS'%*2H"NP4["3MR #[YSWKJZPM
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M6$/$ZZK=J)&QSC$F"1T">W Q78>&XVB\-:;&]K]E9;9 8,$>6=HXY)/'N2:
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M<^5<PK(N?7# BL)?"ECIVNZ?<:'HUAIR1LQN9K:%(?,0J1LPH!;G!YXKJ**
M"L/Q#<3K-IMG'.\$%Y<>3-+&=K!=I. W\)) &1SSQ@UN5'/!#<Q&*>*.6-NJ
M2*&!_ T <]!"=%\166GV=U>307*.TL5U<R7!0 <.'D8L!G QG'/2NEJM;:?9
M63,UI9V\!;AC%$JY^N!5F@#&\0VDE_:Q01VMQ(R2I,DD7ED*R,& (9UR#CM6
M9X9MFL]8N;:XDE$T< $,+Q*A6+/<K(X8YQS\OTKK*J6VF6EI>7%W%&WVBX(\
MR1Y&<_0;B=H]A@4 6Z\U^(VMV[3C1Y-)TEIUC::*YUVWWPM@<B$%2'DQV)'X
M]*]*J&YM;>]MVM[J"*>%QAHY4#*?J#Q0!SWA/PCHVA6Z7MK8VBWL\8+W"6D4
M38/)4>6JX7VKIZHZ7I%GHT#P62RI"S;A&TK.J>RAB=H]AQ5Z@# O?!OAB?SK
MB3PMI%Q<-EBS641=V_WB.OOFKGA^RN=/T2VM;H@RQ@@A3D*,G S["M.B@!&)
M"D@9(' KC[.V_M32)=;O-2OXKR+S"#%=R1Q1;2< Q A&X_O*>OTKL:IRZ1ID
M\QFFTZTDE)R7>!2Q/UQ0 S1;J>]T:UN;@8ED3+<8S[X]^M7B< D G'8=Z4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.gif
M1TE&.#EA( (N 7< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y
M! $     +      @ BX!AP          ,P  9@  F0  S   _P S   S,P S
M9@ SF0 SS  S_P!F  !F,P!F9@!FF0!FS !F_P"9  "9,P"99@"9F0"9S "9
M_P#,  #,,P#,9@#,F0#,S #,_P#_  #_,P#_9@#_F0#_S #__S,  #, ,S,
M9C, F3, S#, _S,S #,S,S,S9C,SF3,SS#,S_S-F #-F,S-F9C-FF3-FS#-F
M_S.9 #.9,S.99C.9F3.9S#.9_S/, #/,,S/,9C/,F3/,S#/,_S/_ #/_,S/_
M9C/_F3/_S#/__V8  &8 ,V8 9F8 F68 S&8 _V8S &8S,V8S9F8SF68SS&8S
M_V9F &9F,V9F9F9FF69FS&9F_V:9 &:9,V:99F:9F6:9S&:9_V;, &;,,V;,
M9F;,F6;,S&;,_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D S)D
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MPF> \#>47O_;R+1+KZ=[GB*]FS0M6DQHTOUJ=U)BTTFE$*/ZBK/L$4G-$8/
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M",;?A4SQVY>XZH\SMY"_UW@H][N3 TN^KZJH:#DMX>*\VSJ;Y'- SU,ZYZ#
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M3$UT\\S(S,W_XXDX2#$]6VQ,.,S#-.1#-EQ#WR2NPN1([AB7XUQ#.61+CQ3
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MXS2^.#66L^MEXS<&)VJUK1T-Q1RN8CBN'=!P(0G1E$(9%/'E8YX*9#Q6(<$
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@Y'[NY8[NYH;NZI9NZZ;NZ];N[.;NZ?9N[/YN[0X( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ 0,# 2(  A$! Q$!_\0
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MWD_'^8%>&>%_&^M>$YP;&X+VQ.7M9?FC;\/X3[C%;QI*I&\=S&51P=I;'O\
MX@URX\)7":A=*]QH<SA)V'+VCGHP_O(?3J#TZ@#HK2[M[^TBNK29)H)5#)(A
MR&%<=H'C3P_\0=*FTR8""YGB*364K<D$<E#_ !?AR/05Y7X=\5ZG\-O$UUI%
MV7GT^*=HYX/Q_P!8GH2,''0C\PE2<DUU0W42L^C/HNBJNG:C::MI\-]8SK/;
M3+N1U[_X'VJU6)J%%%% !114-S=VUG%YMU<101_WY7"C\S0!-16=:>(-%OY/
M+L]7L+A_[L-RCG\@:T:&K %%%% !1110 4444 %%%% !1110 444C,%4LQ
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M;6]E2YW;'MT5@"N,@Y88/-9C?$^RB*&X\.^([>-G">9-9!%!)P,DO7._'?\
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M6^@)/YBNY\&^*;3Q7H,-Y#(OVE5"W,6>8Y,<\>AZ@UT#HKHR.H96&"I&017
MW_PJT\:@VH>']2O-"NC_ ,^QS'US]W(./;./:M5)2CRRZ&?*U+F1WY.!DUS^
M@^*(/$&LZQ;685[/3VCC6X4Y$LAW;\>PPHSWYK!E^'^N:A$UOJ_CC4;FT88>
M*"%82P[@G)R/8BNF\.^&-*\+6+6FEVYC5SND=F+-(?4G_(J6HI;W95Y-GD/P
MJ\*:1XGT+6HM2M%DD#HD<PX>+*GE3]<&MGX:ZU=^&_$=WX'UER"DC?8V;IGJ
M0/9A\P_'UKM/!/@F'P7;7<,-[)="Y=7)= NW (['WJ'Q;\/['Q5?6NH"ZFL=
M0M\!;B #) .1GW!Z'-:RJ*4FGLS-0:2:W1R?QW_Y!>C?]=I/_017K"PQ(VY8
MT!'<**Y#Q/X#?Q;I=A::EJ[F6T9F\^.W"F3( Y&< \=J@F\":Y/ 89/'6K;"
M"#A "0?<'-0W%Q2OL59J3=C'^.#*_A'3F1@RF]!!!R#^[>O2-._Y!=I_UQ3_
M -!%<WXC\!VOB#PSIVA_:Y+:"Q*;'1 Q(5"H_G5(_#_4IK=;6Z\::R]L%V>7
M$5C)'ID9S1>+BE?N%FI-V.6\7D>-?BKI.C:>?-@T[!NI5Y5/F#/S[ */J<5:
M^*'_ "/_ (._Z^%_]&I7H'AWPMI'A:S:WTNV$>_!DD8[GD(]3_3I6?XD\%0^
M(]=TG5)+V2!M.<.L:H"'PP;DYXZ4U47,NR$X.S[LZFO)/AS_ ,E5\9?]=I__
M $>:];KEM \$PZ!XGU;6X[V29]1=W:)D ";GW\'//I41DE&2?4J2;:9U-8UI
MXA@N/%&H:$Y5+FVCCEC&>9$8<D#V/\Q6S7)^)/ -AX@U./5HKNZT[58@ EW;
M/@\=,C\>V*4;=2G?H)\2K/3KKP)J<FH)&?(B,D#MU27HN#[G ]\UQ_@2SNI?
M@EKB,&/GK=-;CKE?+ P/^!*U;DGPUO=6>-/$GBR^U2TC8,+9(A"I/^U@G/\
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/%%%9EA1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
